18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypoglycemia
This purpose of this study is to determine the ability of an 18F-fluoro-L-dihydroxyphenylalanine (18F-DOPA) PET scan to detect a focal lesion of hyperinsulinism and determine the location in patients with congenital hyperinsulinism, Beckwith Wiedemann Syndrome and suspected insulinoma. Safety data will be collected.
|Study Type:||Expanded Access What is Expanded Access?|
|Official Title:||Expanded Access Use of 18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypoglycemia|
Please refer to this study by its ClinicalTrials.gov identifier: NCT01916148
|Contact: Susan Becker, RN, BSN, CCRC||267-426-0269||Beckers@email.chop.edu|
|Contact: Lisa States, MD||267-425-7146||States@email.chop.edu|